(Q45276886)

English

Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study

scientific article

Statements

Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study (English)
Mohammad Ali Sadiq
Lawrence Halperin
Peter A Campochiaro
Quan Dong Nguyen
READ-3 Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit